期刊文献+

阿瓦斯丁对HaCaT细胞体外增殖及其VEGF表达的影响

Effect of Avastin on the Proliferation and the Expression of VEGF in Cultured HaCaT Cells
下载PDF
导出
摘要 目的探讨阿瓦斯丁对HaCaT细胞体外增殖及VEGF表达的影响。方法体外培养HaCaT细胞,不同浓度阿瓦斯丁分别作用24h,48h和72h后,CCK-8法检测阿瓦斯丁对HaCaT细胞体外增殖的抑制作用;Western印迹和RT-PCR法检测不同浓度阿瓦斯丁作用HaCaT细胞48h后对HaCaT细胞VEGF蛋白及mRNA表达的影响。结果不同浓度阿瓦斯丁对HaCaT细胞的体外增殖均具有抑制作用,且这种抑制作用具有剂量依赖性,与对照组相比差异有统计学意义(P<0.05);不同浓度阿瓦斯丁作用HaCaT细胞48h后,VEGF蛋白及mRNA的表达下调,与对照组相比差异有统计学意义(P<0.05)。结论阿瓦斯丁可抑制HaCaT细胞的体外增殖并且能抑制VEGF蛋白及mRNA的表达。 Objective To investigate the effects of Avastin on proliferation and VEGF expression in cultured HaCaT cells. Methods Cultured HaCaT cells were treated with different concentrations of Avastin. The changes of cell proliferation were determined by CCK-8 assay at 24h,48h and 72h after the treatment. RT-PCR and Western blot were used to detect the expression of VEGF mRNA and protein at 48h after the treatment. Results Avastin at all tested concentrations inhibited HaCaT cell proliferation in dose dependent manner (P 〈 0.05). By 24h after treatment avastin at all tested concentrations significantly lowered the expression levels of VEGF protein and mRNA as compared to vehicle(P 〈 0.05). Conclusion Avastin inhibits HaCaT cell proliferation, and the expression of VEGF protein and mRNA.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2013年第9期867-869,872,共4页 The Chinese Journal of Dermatovenereology
关键词 HACAT细胞 阿瓦斯丁 增殖 VEGF HaCaT cells Avastin Proliferation VEGF
  • 相关文献

参考文献13

  • 1Henno A, Blather S, Lambert CA, et al. Histological and transcrip- tional study of angiogenesis and lymphangiugenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: an approach of vascular development chronology in psoriasis [ J ]. Dermatol Sei, 2010, 57( 3 ) :162 - 169.
  • 2Armstrong AW, Voyles SV, Armstrong E J, et al. Angiogenesis and oxi- dative stress:Common mechanisms linking psoriasis with atherosclerosis [J]. Dermatol Sci,2011,63( 1 ) :1 -9.
  • 3Zhou CL, Yu XJ, Chen LM, et al. Corticopin-releasing hormone atten- uates vascular endothelial growth factor release from human HaCaT ke- ratinocytes [ J ]. Regul Pept,2010,160 ( 1-3 ) : 115 - 120.
  • 4Heidenreich R, Rocken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis [ J ]. Int J Exp Patho1,2009,90 ( 3 ) :232 - 248.
  • 5Kiselyov A, Balakin KV, Tkachenko SE. VEGF/VEGFR signaling as a target for inhibiting angiogenesis [ J ]. Expert Opin Investing Drugs, 2007,16(1) :83 - 107.
  • 6Akman A, Yilmaz E, Mutlu H, et al. Complete remission of psoriasis following bevacizumab therapy for colon cancer[ J]. Clin Exp Dermatol, 2009,34(5) :e202-204.
  • 7杨晓红,满孝勇,蔡绥勍,李春明,周炯,郑敏.VEGF在HaCaT细胞中的自分泌作用[J].浙江大学学报(医学版),2009,38(4):338-342. 被引量:5
  • 8Zhao TT, Trinh D, Addison CL, et al. Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFRInhibitors [ J ]. PLoS One ,2010,5 (9) : e12563.
  • 9Elias PM, Arbiser J, Brown BE, et al. Epidermal vascular endothelial growth factor production is required for permeability barrier homeosta- sis, dermal angiogenesis and the development of epidermal hyperplasia : implications for the pathogenesis of psoriasis [ J ]. Am J Pathol, 2008, 173(3) :689 -99.
  • 10Zhang Y, Furumura M, Morita E. Distinct signaling pathways confer different vascular responses to VEGFI21 and VEGFI65 [J]. Growth Fac- tors,2008,26(3) :125 - 131.

二级参考文献1

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部